Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BB Biotech is a leading Swiss investment company focused on the biotechnology sector. The company invests in innovative firms developing groundbreaking therapies for diseases with high unmet medical needs, providing investors with direct access to this high-growth market.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BB Biotech is scheduled to report its next quarterly earnings on 10/23/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BB Biotech last reported quarterly earnings on 1/23/2026 (Q4 2025). Earnings per share (EPS) came in at 10.54 CHF.
For fiscal year 2026, BB Biotech paid a dividend of 2.25 CHF per share.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
| Fiscal year | Dividend per share |
|---|---|
| 2026 | 2.25 CHF |
| 2025 | 1.80 CHF |
| 2024 | 2.00 CHF |
| 2023 | 2.85 CHF |
| 2022 | 3.85 CHF |
| 2021 | 3.60 CHF |
| 2020 | 3.40 CHF |
| 2019 | 3.05 CHF |
| 2018 | 3.30 CHF |
| 2017 | 2.75 CHF |
| 2016 | 2.90 CHF |
| 2015 | 2.32 CHF |
… and 2 more fiscal years
Source: BB Biotech investor relations, 14 fiscal years.
Past dividends are no guarantee of future payouts.